Weight loss drugs and the risk of macular degeneration

episode

Health Report - Separate stories podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

9/24/26: Nvidia CEO Warns On AI, Professor Pape Dire Election Warning, Bay Of Piglets Survivors Speak Out 1h 16m · 24 Sep 2026 · Breaking Points with Krystal and Saagar

9/24/26: Trump Backs Diesel Export Ban, Latinos Flee GOP, Iran Lashes Out At Israel 1h 11m · 24 Sep 2026 · Breaking Points with Krystal and Saagar

2026-09-24- KSR - Hour 1 1h 4m · 24 Sep 2026 · KSR

Football vs jetlag | Who is the Mayo of the NFL? | Super Bowl favourites | Hockey's coaching scandal | US Sports Roundtable 1h 11m · 24 Sep 2026 · Indo Sport

First Date Follow Up: A Revenge Date With a CRAZY Twist! 17 min · 24 Sep 2026 · First Date Follow Up - The Jubal Show

Jason Sudeikis: JUCO Hoops, SNL & Why Apple Bet on Ted Lasso 1h 24m · 24 Sep 2026 · All The Smoke

Report any issue

Source

Recorded11 Jul 2025

Publisherabc.net.au ↗

Handlerec:19039190

Show notes

GLP-1 agonists, like Ozempic and Wegovy, have been heralded as miracle drugs.They started out as diabetes drugs, but have shown benefits well beyond diabetes – including in weight loss and other metabolic conditions.However these are new drugs, and as more and more people take them, researchers are keeping tabs on their effects.While the risk is small, there are potential eye-related side effects. A new study has looked into macular degeneration in particular.Guest/sDr Marko Popovic, ophthalmologist and retina specialist at the University of TorontoReferencesGLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in